<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Archives des Examples of past transactions - Bucephale Finance</title>
	<atom:link href="https://www.bucephale.finance/en/portfolio_cat/examples-of-past-transactions/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.bucephale.finance/en/portfolio_cat/examples-of-past-transactions/</link>
	<description>Independent, imaginative, discreet advice</description>
	<lastBuildDate>Thu, 09 Jun 2022 08:14:09 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://www.bucephale.finance/wp-content/uploads/2021/09/cropped-BF_logo-1-32x32.png</url>
	<title>Archives des Examples of past transactions - Bucephale Finance</title>
	<link>https://www.bucephale.finance/en/portfolio_cat/examples-of-past-transactions/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Acquisition of Zentiva by Advent</title>
		<link>https://www.bucephale.finance/en/portfolio/acquisition-of-zentiva-by-advent/</link>
		
		<dc:creator><![CDATA[plutot]]></dc:creator>
		<pubDate>Sat, 14 May 2022 13:59:51 +0000</pubDate>
				<guid isPermaLink="false">https://www.bucephale-finance.com/?post_type=udesign_portfolio&#038;p=7812</guid>

					<description><![CDATA[<p>In September 2018, Advent acquired Zentiva from Sanofi for an enterprise value of €1,919 million. Bucéphale Finance acted as financial advisor to Advent International in this transaction.</p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/acquisition-of-zentiva-by-advent/">Acquisition of Zentiva by Advent</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">In September 2018, Advent acquired Zentiva from Sanofi for an enterprise value of €1,919 million.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">Bucéphale Finance acted as financial advisor to Advent International in this transaction.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><a href="https://www.bucephale.finance/en/our-references/">Back ></a></p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/acquisition-of-zentiva-by-advent/">Acquisition of Zentiva by Advent</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Acquisition of SVS by Cristal Union￼</title>
		<link>https://www.bucephale.finance/en/portfolio/acquisition-of-svs-by-cristal-union/</link>
		
		<dc:creator><![CDATA[plutot]]></dc:creator>
		<pubDate>Sat, 14 May 2022 14:29:42 +0000</pubDate>
				<guid isPermaLink="false">https://www.bucephale-finance.com/?post_type=udesign_portfolio&#038;p=7844</guid>

					<description><![CDATA[<p>In January 2012, Cristal Union completed the €1,000 million acquisition of SVS. Bucéphale Finance acted as exclusive financial advisor to Cristal Union in this transaction.</p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/acquisition-of-svs-by-cristal-union/">Acquisition of SVS by Cristal Union￼</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">In January 2012, Cristal Union completed the €1,000 million acquisition of SVS.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">Bucéphale Finance acted as exclusive financial advisor to Cristal Union in this transaction.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><a href="https://www.bucephale.finance/en/our-references/">Back ></a></p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/acquisition-of-svs-by-cristal-union/">Acquisition of SVS by Cristal Union￼</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Acquisition of Marie Brizard by Belvédère</title>
		<link>https://www.bucephale.finance/en/portfolio/acquisition-of-marie-brizard-by-belvedere/</link>
		
		<dc:creator><![CDATA[plutot]]></dc:creator>
		<pubDate>Sat, 14 May 2022 15:04:26 +0000</pubDate>
				<guid isPermaLink="false">https://www.bucephale-finance.com/?post_type=udesign_portfolio&#038;p=7879</guid>

					<description><![CDATA[<p>In May 2006, Belvédère acquired via a tender offer and squeeze-out Marie Brizard for €398 million. Bucéphale Finance acted as exclusive financial advisor to Belvédère in this transaction.</p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/acquisition-of-marie-brizard-by-belvedere/">Acquisition of Marie Brizard by Belvédère</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">In May 2006, Belvédère acquired via a tender offer and squeeze-out Marie Brizard for €398 million.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">Bucéphale Finance acted as exclusive financial advisor to Belvédère in this transaction.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><a href="https://www.bucephale.finance/en/our-references/">Back ></a></p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/acquisition-of-marie-brizard-by-belvedere/">Acquisition of Marie Brizard by Belvédère</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Disposal of SEGAP stake by CCI Marseille Provence</title>
		<link>https://www.bucephale.finance/en/portfolio/disposal-of-segap-stake-by-cci-marseille-provence/</link>
		
		<dc:creator><![CDATA[plutot]]></dc:creator>
		<pubDate>Sat, 14 May 2022 14:05:08 +0000</pubDate>
				<guid isPermaLink="false">https://www.bucephale-finance.com/?post_type=udesign_portfolio&#038;p=7814</guid>

					<description><![CDATA[<p>In June 2018, CCI Marseille Provence sold its 50% equity interest in its joint venture with the EGIS group in SEGAP, which owns interests in the airports of Abidjan (Ivory Coast), Libreville (Gabon), Brazzaville, Pointe Noire and Ollombo (Congo) to AIIM. Bucéphale Finance acted as financial advisor of CCI-MP in this transaction.</p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/disposal-of-segap-stake-by-cci-marseille-provence/">Disposal of SEGAP stake by CCI Marseille Provence</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">In June 2018, CCI Marseille Provence sold its 50% equity interest in its joint venture with the EGIS group in SEGAP, which owns interests in the airports of Abidjan (Ivory Coast), Libreville (Gabon), Brazzaville, Pointe Noire and Ollombo (Congo) to AIIM.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">Bucéphale Finance acted as financial advisor of CCI-MP in this transaction.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><a href="https://www.bucephale.finance/en/our-references/">Back ></a></p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/disposal-of-segap-stake-by-cci-marseille-provence/">Disposal of SEGAP stake by CCI Marseille Provence</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Disposal of Photonis by Astorg￼</title>
		<link>https://www.bucephale.finance/en/portfolio/disposal-of-photonis-by-astorg/</link>
		
		<dc:creator><![CDATA[plutot]]></dc:creator>
		<pubDate>Sat, 14 May 2022 14:31:13 +0000</pubDate>
				<guid isPermaLink="false">https://www.bucephale-finance.com/?post_type=udesign_portfolio&#038;p=7846</guid>

					<description><![CDATA[<p>In October 2011, Astorg sold its stake in Photonis to Axa Private Equity for €505 million. Bucéphale Finance acted as exclusive financial advisor to Astorg Partners in this transaction.</p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/disposal-of-photonis-by-astorg/">Disposal of Photonis by Astorg￼</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">In October 2011, Astorg sold its stake in Photonis to Axa Private Equity for €505 million.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">Bucéphale Finance acted as exclusive financial advisor to Astorg Partners in this transaction.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><a href="https://www.bucephale.finance/en/our-references/">Back ></a></p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/disposal-of-photonis-by-astorg/">Disposal of Photonis by Astorg￼</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Acquisition of a minority stake in DCN by Thales</title>
		<link>https://www.bucephale.finance/en/portfolio/acquisition-of-a-minority-stake-in-dcn-by-thales/</link>
		
		<dc:creator><![CDATA[plutot]]></dc:creator>
		<pubDate>Sat, 14 May 2022 15:07:48 +0000</pubDate>
				<guid isPermaLink="false">https://www.bucephale-finance.com/?post_type=udesign_portfolio&#038;p=7881</guid>

					<description><![CDATA[<p>In December 2005, Thales acquired 25% of DCN for €1.3 billion. Bucéphale Finance was mandated to provide a fairness opinion in this transaction.</p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/acquisition-of-a-minority-stake-in-dcn-by-thales/">Acquisition of a minority stake in DCN by Thales</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">In December 2005, Thales acquired 25% of DCN for €1.3 billion.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">Bucéphale Finance was mandated to provide a fairness opinion in this transaction.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><a href="https://www.bucephale.finance/en/our-references/">Back ></a></p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/acquisition-of-a-minority-stake-in-dcn-by-thales/">Acquisition of a minority stake in DCN by Thales</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Acquisition of a stake in Provepharm by Archimed and Téthys</title>
		<link>https://www.bucephale.finance/en/portfolio/acquisition-of-a-stake-in-provepharm-by-archimed-and-tethys/</link>
		
		<dc:creator><![CDATA[plutot]]></dc:creator>
		<pubDate>Sat, 14 May 2022 14:06:13 +0000</pubDate>
				<guid isPermaLink="false">https://www.bucephale-finance.com/?post_type=udesign_portfolio&#038;p=7816</guid>

					<description><![CDATA[<p>In March 2018, Archimed and Téthys acquired a minority stake in Provepharm alongside its founders and the historical shareholders. Bucéphale Finance acted as exclusive financial advisor to its founders and the sellers in this transaction.</p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/acquisition-of-a-stake-in-provepharm-by-archimed-and-tethys/">Acquisition of a stake in Provepharm by Archimed and Téthys</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">In March 2018, Archimed and Téthys acquired a minority stake in Provepharm alongside its founders and the historical shareholders.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">Bucéphale Finance acted as exclusive financial advisor to its founders and the sellers in this transaction.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><a href="https://www.bucephale.finance/en/our-references/">Back ></a></p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/acquisition-of-a-stake-in-provepharm-by-archimed-and-tethys/">Acquisition of a stake in Provepharm by Archimed and Téthys</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Equity fundraising for NGE￼</title>
		<link>https://www.bucephale.finance/en/portfolio/equity-fundraising-for-nge/</link>
		
		<dc:creator><![CDATA[plutot]]></dc:creator>
		<pubDate>Sat, 14 May 2022 14:32:36 +0000</pubDate>
				<guid isPermaLink="false">https://www.bucephale-finance.com/?post_type=udesign_portfolio&#038;p=7848</guid>

					<description><![CDATA[<p>In September 2011, FSI (Fonds Stratégique d’Investissement) invested €80m in NGE in order to finance its strategic acquisition project of TSO. Bucéphale Finance acted as exclusive financial advisor to the FSI in this transaction.</p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/equity-fundraising-for-nge/">Equity fundraising for NGE￼</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">In September 2011, FSI (Fonds Stratégique d’Investissement) invested €80m in NGE in order to finance its strategic acquisition project of TSO.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">Bucéphale Finance acted as exclusive financial advisor to the FSI in this transaction.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><a href="https://www.bucephale.finance/en/our-references/">Back ></a></p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/equity-fundraising-for-nge/">Equity fundraising for NGE￼</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Acquisition of Geoservices by Astorg￼</title>
		<link>https://www.bucephale.finance/en/portfolio/acquisition-of-geoservices-by-astorg/</link>
		
		<dc:creator><![CDATA[plutot]]></dc:creator>
		<pubDate>Sat, 14 May 2022 15:09:12 +0000</pubDate>
				<guid isPermaLink="false">https://www.bucephale-finance.com/?post_type=udesign_portfolio&#038;p=7883</guid>

					<description><![CDATA[<p>In July 2005, Astorg acquired Geoservices for €241 million. Bucéphale Finance acted as exclusive financial advisor to Astorg in this transaction.</p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/acquisition-of-geoservices-by-astorg/">Acquisition of Geoservices by Astorg￼</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">In July 2005, Astorg acquired Geoservices for €241 million.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">Bucéphale Finance acted as exclusive financial advisor to Astorg in this transaction.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><a href="https://www.bucephale.finance/en/our-references/">Back ></a></p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/acquisition-of-geoservices-by-astorg/">Acquisition of Geoservices by Astorg￼</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Acquisition of Organic Alliance by Cerea Partenaire</title>
		<link>https://www.bucephale.finance/en/portfolio/acquisition-of-organic-alliance-by-cerea-partenaire/</link>
		
		<dc:creator><![CDATA[plutot]]></dc:creator>
		<pubDate>Sat, 14 May 2022 14:08:03 +0000</pubDate>
				<guid isPermaLink="false">https://www.bucephale-finance.com/?post_type=udesign_portfolio&#038;p=7818</guid>

					<description><![CDATA[<p>In December 2017, Cerea Partenaire with its co-investors Unigrains and MACSF acquired Organic Alliance from Naxicap Partners. Bucéphale Finance acted as exclusive financial advisor to Cerea Partenaire in this transaction.</p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/acquisition-of-organic-alliance-by-cerea-partenaire/">Acquisition of Organic Alliance by Cerea Partenaire</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">In December 2017, Cerea Partenaire with its co-investors Unigrains and MACSF acquired Organic Alliance from Naxicap Partners.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">Bucéphale Finance acted as exclusive financial advisor to Cerea Partenaire in this transaction.</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><a href="https://www.bucephale.finance/en/our-references/">Back ></a></p>
<p>L’article <a href="https://www.bucephale.finance/en/portfolio/acquisition-of-organic-alliance-by-cerea-partenaire/">Acquisition of Organic Alliance by Cerea Partenaire</a> est apparu en premier sur <a href="https://www.bucephale.finance/en/home">Bucephale Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
